Objective: Generalized anxiety disorder (GAD) is common, chronic, and debilitating.
Treatment with benzodiazepines and newer antidepressants is often inadequate. This article …

Introduction: Modest response and remission rates for the selective serotonin reuptake
inhibitors and the serotonin-norepinephrine reuptake inhibitors, coupled with mounting …

Many patients with generalized anxiety disorder (GAD) do not receive adequate treatment.
Several classes of drugs, including benzodiazepines, azapirones, selective serotonin …

Less than one third of people afflicted with generalized anxiety disorder (GAD) experience
spontaneous remission, and the symptoms of GAD wax and wane throughout a person's life …

Selection of appropriate treatment for generalized anxiety disorder (GAD) is influenced by
several considerations, including psychiatric comorbidity. Emerging data suggest that GAD …

Generalized anxiety disorder (GAD) is a relatively common presentation in primary care and
a significant vulnerability factor for future morbidity, particularly depression and alcohol …

Clinical and epidemiological data suggest that generalized anxiety disorder (GAD) is a
chronic illness causing patients to suffer for many years leading to significant distress in …

Objective: To provide primary care clinicians with a better understanding of management
issues in generalized anxiety disorder (GAD) and guide clinical practice with …

In recent years generalised anxiety disorder (GAD) has become a much better defined
disorder, with specific criteria distinguishing it from the other anxiety disorders; however, it …

Generalized anxiety disorder (GAD) is a chronic disorder that frequently co-occurs with a
variety of co-morbidities in patients with somatic conditions and other mental disorders. GAD …